课题基金 / 基金详情

项目摘要

项目成果

Stella M Papa的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用资源的许多研究子项目之一。 由NIH/NCRR资助的中心拨款提供。对子项目的主要支持 子项目的首席调查员可能是由其他来源提供的, 包括美国国立卫生研究院的其他来源。为子项目列出的总成本可能 表示该子项目使用的中心基础设施的估计数量, 不是由NCRR赠款提供给次级项目或次级项目工作人员的直接资金。 本项目评估帕金森氏病(PD)演变过程中出现的异常运动症状的病理生理学。多巴胺替代在早期阶段有有益的效果,但长期治疗往往无法完全恢复正常活动能力,甚至可能产生额外的运动异常。多巴胺反应的改变与多巴胺受体介导的纹状体神经元活动调节机制的变化有关。然而,其他神经递质系统的变化也可能起到一定作用。在本项目前期研究的基础上,我们继续研究纹状体谷氨酸能传递在左旋多巴异常反应的病理生理学中的作用。这些研究的目标是确定能够为帕金森病的长期治疗开发新的治疗方法的药理靶点。本研究包括四个方面的内容:(1)研究帕金森病猴纹状体中棘神经元(MSN)谷氨酸能高反应与神经元放电改变的关系。MSN的电生理记录与纹状体注射特定的谷氨酸受体拮抗剂相结合。(2)观察谷氨酸释放增加是否与MSN放电改变有关。我们将通过将大麻素CB1作用药物注入帕金森病猴的壳核来降低谷氨酸能水平,以研究MSN放电的变化和左旋多巴运动反应。(3)研究慢性帕金森病患者纹状体间接输出的变化及其与多巴胺能药物反应异常的关系。我们将在壳核输注中使用谷氨酸拮抗剂,并记录正常和帕金森病猴子苍白球外段的神经元活动。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. This project evaluates the pathophysiology of abnormal motor symptoms developed in the evolution of Parkinson's disease (PD). Dopamine replacement has beneficial effects in the early stages, but long-term therapy often fails to completely restore normal mobility, and may even produce additional motor abnormalities. Altered dopamine responses have been related to changes in dopamine receptor-mediated mechanisms regulating the activity of striatal neurons. However, changes in other neurotransmitter systems may also play a role. Based on our previous studies in this project, we focus our continuation studies on the role of striatal glutamatergic transmission in the pathophysiology of abnormal responses to levodopa. The goal of these studies is to identify pharmacologic targets that could serve to develop new treatments for the long-term therapy of PD. The project comprises four aims: (1) To study the relationship between glutamatergic hyperactivity and altered discharges of striatal medium spiny neurons (MSNs) in parkinsonian monkeys. Electrophysiologic recordings of MSNs are combined with striatal injections of specific glutamate receptor antagonists. (2) To examine whether increased glutamate release is involved in the altered MSN discharges. We will reduce glutamatergic levels with cannabinoid CB1-acting drugs infused into the putamen of parkinsonian monkeys to study MSN firing changes and levodopa motor responses. (3) To study the changes in indirect striatal outputs that develop in chronic PD and are associated with abnormal responses to dopaminergic drugs. We will use glutamate antagonists in putaminal infusions and record the neuronal activity of the external segment of the globus pallidus in normal and parkinsonian monkeys.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene therapy targeting striatal dysfunction for Parkinson’s disease
  • 批准号:
    10557885
  • 项目类别:
  • 资助金额:
    $56.15万
  • 财政年份:
    2022
  • 负责人:
    Stella M Papa
  • 依托单位:
Dopamine signal transduction in striatal neurons in Parkinson’s disease
  • 批准号:
    10353674
  • 项目类别:
  • 资助金额:
    $50.05万
  • 财政年份:
    2021
  • 负责人:
    Stella M Papa
  • 依托单位:
NMDA RECEPTOR AS THERAPEUTIC TARGET FOR PARKINSON?S DISEASE
  • 批准号:
    8357477
  • 项目类别:
  • 资助金额:
    $3.29万
  • 财政年份:
    2011
  • 负责人:
    Stella M Papa
  • 依托单位:
MOTOR EFFECTS OF PDE10A INHIBITORS IN PRIMATES
  • 批准号:
    8357478
  • 项目类别:
  • 资助金额:
    $4.12万
  • 财政年份:
    2011
  • 负责人:
    Stella M Papa
  • 依托单位:
海外基金